In June 2024, Illumina, Inc. (US) announced the launch of DRAGEN v4.3, the latest version of its DRAGEN software, part of the Illumina Connected Software portfolio, for analysis of next-generation sequencing data. In January 2024, Natera, Inc. (US) announced that it had acquired certain assets from Invitae Corporation (US) related to Invitae’s non-invasive prenatal screening and carrier screening business.
Comments
0 comment